|
Tivozanib Clinical Trials
3 actively recruiting trials across 3 locations
Also known as: AV951, AV951 cpd, KRN 951, KRN-951, KRN951 +1 more
Pipeline
Phase 2: 1Phase 3: 1Phase 1/2: 1
Top Sponsors
- National Cancer Institute (NCI)1
- M.D. Anderson Cancer Center1
- Alliance for Clinical Trials in Oncology1
Indications
- Cancer3
- Biliary Tract Malignancy1
- Bile Duct Neoplasm1
- Stage III Renal Pelvis Cancer AJCC v81
- Stage II Renal Pelvis Cancer AJCC v81
Phoenix, Arizona1 trial
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Cancer Center at Saint Joseph's
Phase 3
Bethesda, Maryland1 trial
Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
National Institutes of Health Clinical Center
Phase 1/2
Boston, Massachusetts1 trial
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
Beth Israel Deaconess Medical Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.